Inscripta Stock
Inscripta® is a pioneering life science technology company dedicated to advancing the vision of a cleaner, healthier, and more sustainable world through biomanufacturing. As a globally recognized leader in genome engineering, Inscripta's ground-breaking innovations are specifically engineered to unlock the full potential of the bioeconomy. With an unwavering commitment to continuously advancing critical technologies, Inscripta empowers scientists to strengthen and broaden domestic biomanufacturing capabilities while also catalyzing the development of new, safe, and secure biotech innovations.
Sign up for SecondMarket™ to view the market and buy or sell Inscripta Stock
Buy + SellInscripta Funding
Sign up to gain insights into Inscripta funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Dec 13, 2022 | Series E | 27.79M | ||
| Mar 30, 2021 | Series E | 150.00M | ||
| Nov 27, 2019 | Series D | 92.15M | ||
| Apr 10, 2019 | Series C | 24.35M | ||
| Jan 04, 2019 | Series C | 25.65M | ||
| Feb 20, 2018 | Series C | 55.50M | ||
| Feb 16, 2017 | Series B | 23.00M | ||
| Apr 29, 2016 | Series A | 6.04M |
See Inscripta Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Inscripta Stock Valuation + Share Prices
View real-time Tape D™ data on Inscripta stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Inscripta Management Team
CFO, COO
Ed Tang
Chief Customer Officer
Aditya Phadke
CFO
Lisa Davidson
Chief Product & Technology Officer
Rohan Chandran
Director
Roger B Wyse
Director
Kristala Prather
President, CEO, Director
Sri Kosaraju
Chief Innovation Officer
Andrew Garst
Chief Technology Officer
Ted Tarasow
Director
Bryan E. Roberts
Chairman
John R. Stuelpnagel
Director
Scott Kupor
Director
Frank Slootman
Director
Toni Schneider
Inscripta Major Investors
Oak HC/FT Partners
Paladin Capital Group
JS Capital Management LLC
Venrock, Inc.
Venrock, Inc.
Spruce Capital Partners
Durable Capital Partners
NanoDimension Management, Ltd.
NanoDimension Management, Ltd.
Foresite Capital Management LLC
Merieux Developpement SASU
MLS Capital (MLSF)
Foresite Capital
D1 Capital Partners
Fidelity Management & Research Company
Counterpoint Global
